QuickGly™ is the world’s first non-invasive device that measures glycated hemoglobin (HbA1c) in real-time, essential for diabetes management. Unlike devices that measure blood sugar, it measures HbA1c, reflecting the average blood sugar level over the past three months.

We hold related patents (9 Korean registered, 4 US pending). Diabetes can be diagnosed at low cost, and HbA1c easily measured anytime, anywhere. The device connects to iOS and Android via Bluetooth, making it easy to monitor values.

Our patented product enables remote diagnosis of diabetes and contributes to health promotion, especially in underdeveloped countries, by offering free patent licenses.